CYP2C19But NotPON1Genetic Variants Influence Clopidogrel Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy in Post–Myocardial Infarction Patients-Reference-Cited by-同舟云学术

CYP2C19But NotPON1Genetic Variants Influence Clopidogrel Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy in Post–Myocardial Infarction Patients

Published:2011-10 Issue:5 Volume:4 Page:422-428
ISSN:1941-7640
Container-title:Circulation: Cardiovascular Interventions
language:en
Short-container-title:Circ Cardiovasc Interv

Author:

Hulot Jean-Sébastien¹,Collet Jean-Philippe¹,Cayla Guillaume¹,Silvain Johanne¹,Allanic Frédérick¹,Bellemain-Appaix Anne¹,Scott Stuart A.¹,Montalescot Gilles¹

Affiliation:

1. From Université Pierre et Marie Curie-Paris 6, INSERM UMR S 956, Pharmacology Department, Pitié-Salpêtrière University Hospital, Paris, France (J.-S.H., F.A.); the Cardiovascular Research Center, Mount Sinai School of Medicine, New York, NY (J.-S.H.); Institut de Cardiologie, INSERM CMR937, Pitié-Salpêtrière Hospital (AP-HP) 75013, and Université Pierre et Marie Curie, Paris, France (J.-P.C., G.C., J.S., A.B.-A., G.M.); and the Department of Genetics and Genomics Sciences, Mount Sinai School of...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Variability in platelet responsiveness to clopidogrel among 544 individuals

2. Clopidogrel for Coronary Stenting

3. Impact of the Degree of Peri-Interventional Platelet Inhibition After Loading With Clopidogrel on Early Clinical Outcome of Elective Coronary Stent Placement

4. Impact of Platelet Reactivity After Clopidogrel Administration on Drug-Eluting Stent Thrombosis

5. Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances and Perspectives in methods for identifying high platelet reactivity;Heliyon;2023-12

2. Association between Q192R PON1 genetic polymorphism and major adverse cardiovascular events in patients treated with clopidogrel: an updated meta-analysis;Expert Opinion on Drug Safety;2023-05-08

3. Pharmacogenetics of cardiovascular drugs;Current Opinion in Cardiology;2023-03-28

4. Multiple genetic mutations increase the risk of thrombosis associated with clopidogrel after percutaneous coronary intervention;Pharmacogenomics;2023-03

5. Pharmacogenomics in Cardiovascular Diseases;Pharmacogenomics in Clinical Practice;2023